The role of HER2 in canine mammary carcinoma is controversial; therefore, this study aimed to investigate the protein expression and cytogenetic alterations of HER2 and their correlation with the proliferative fraction, estrogen receptor, and other clinicopathological parameters in canine mammary carcinoma. This evidence concerns the gene ESR1 and breast carcinoma.